Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
出版年份 2018 全文链接
标题
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
作者
关键词
-
出版物
Oxidative Medicine and Cellular Longevity
Volume 2018, Issue -, Pages 1-15
出版商
Hindawi Limited
发表日期
2018-03-19
DOI
10.1155/2018/7582730
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Doxorubicin targets multiple players: A new view of an old problem
- (2018) Donato Cappetta et al. PHARMACOLOGICAL RESEARCH
- Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity
- (2017) Donato Cappetta et al. Oxidative Medicine and Cellular Longevity
- The mitochondrial metabolic reprogramming agent trimetazidine as an ‘exercise mimetic’ in cachectic C26-bearing mice
- (2017) Francesca Molinari et al. Journal of Cachexia Sarcopenia and Muscle
- Targeted overexpression of mitochondrial catalase protects against cancer chemotherapy-induced skeletal muscle dysfunction
- (2016) Laura A. A. Gilliam et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?
- (2016) James C. Sorensen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN JOURNAL OF HEART FAILURE
- Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction
- (2016) Antonella De Angelis et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Animal models of cardiac cachexia
- (2016) Francesca Molinari et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy
- (2016) Donato Cappetta et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Correction: Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle
- (2016) Francesca Pretto et al. Oncotarget
- Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?
- (2016) Gennaro Riccio et al. Human Vaccines & Immunotherapeutics
- Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine
- (2016) Elisabetta Ferraro et al. Journal of Cachexia Sarcopenia and Muscle
- mtDNA damage in the development of heart failure
- (2015) Alyssa A. Lombardi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Impaired dynamics and function of mitochondria caused by mtDNA toxicity leads to heart failure
- (2015) Knut H. Lauritzen et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Apaf1-deficient cortical neurons exhibit defects in axonal outgrowth
- (2015) Daniela De Zio et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Muscle wasting in cancer
- (2015) Josep M. Argilés et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer
- (2015) Stefania Mantarro et al. Internal and Emergency Medicine
- SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells
- (2015) Antonella De Angelis et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy
- (2015) Kisuk Min et al. JOURNAL OF PHYSIOLOGY-LONDON
- Skeletal Muscle an Active Compartment in the Sequestering and Metabolism of Doxorubicin Chemotherapy
- (2015) Sergio Fabris et al. PLoS One
- Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction
- (2014) Carlo G. Tocchetti et al. EUROPEAN JOURNAL OF HEART FAILURE
- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
- (2014) Tomáš Šimůnek et al. Pharmacological Reports
- Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients
- (2013) O Huillard et al. BRITISH JOURNAL OF CANCER
- The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubes
- (2013) Elisabetta Ferraro et al. FEBS Journal
- The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle
- (2013) Laura A.A. Gilliam et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
- (2013) Adrian S Dobs et al. LANCET ONCOLOGY
- Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study
- (2013) M. Bonifazi et al. ONCOLOGIST
- Mitochondria: gatekeepers of response to chemotherapy
- (2013) Kristopher A. Sarosiek et al. TRENDS IN CELL BIOLOGY
- After the chemotherapy: potential mechanisms for chemotherapy-induced delayed skeletal muscle dysfunction in survivors of acute lymphoblastic leukaemia in childhood
- (2013) Celena Scheede-Bergdahl et al. Frontiers in Pharmacology
- Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection
- (2012) Martin Štěrba et al. ANTIOXIDANTS & REDOX SIGNALING
- Mitochondrial dysfunction mediated cisplatin induced toxicity: Modulatory role of curcumin
- (2012) Mohammad Waseem et al. FOOD AND CHEMICAL TOXICOLOGY
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
- (2012) Yanti Octavia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle function
- (2012) Reid Hayward et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects
- (2012) Steen Larsen et al. JOURNAL OF PHYSIOLOGY-LONDON
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
- (2012) E. J. A. Bowles et al. JNCI-Journal of the National Cancer Institute
- Doxorubicin induced myocardial injury is exacerbated following ischaemic stress via opening of the mitochondrial permeability transition pore
- (2012) M. Gharanei et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism
- (2012) Yan Ding et al. Nature Communications
- Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes
- (2011) Laura A. A. Gilliam et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Chemotherapy-Induced Weakness and Fatigue in Skeletal Muscle: The Role of Oxidative Stress
- (2011) Laura A.A. Gilliam et al. ANTIOXIDANTS & REDOX SIGNALING
- PARP-2 Regulates SIRT1 Expression and Whole-Body Energy Expenditure
- (2011) Péter Bai et al. Cell Metabolism
- PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 Activation
- (2011) Péter Bai et al. Cell Metabolism
- Heart Failure Associated with Sunitinib: Lessons Learned from Animal Models
- (2011) Colin F. Greineder et al. CURRENT HYPERTENSION REPORTS
- Exercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle
- (2011) Ashley J. Smuder et al. JOURNAL OF APPLIED PHYSIOLOGY
- Effects of a home-based exercise program on metabolic risk factors and fitness in long-term survivors of childhood acute lymphoblastic leukemia
- (2011) Liisa S. Järvelä et al. PEDIATRIC BLOOD & CANCER
- The DNA repair complex Ku70/86 modulates Apaf1 expression upon DNA damage
- (2010) D De Zio et al. CELL DEATH AND DIFFERENTIATION
- Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2010) Thomas Eschenhagen et al. EUROPEAN JOURNAL OF HEART FAILURE
- The sites and topology of mitochondrial superoxide production
- (2010) Martin D. Brand EXPERIMENTAL GERONTOLOGY
- Women survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapy
- (2010) Nicola Maurea et al. Journal of Cardiovascular Medicine
- Cardiomyocyte PDGFR-β signaling is an essential component of the mouse cardiac response to load-induced stress
- (2010) Vishnu Chintalgattu et al. JOURNAL OF CLINICAL INVESTIGATION
- Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy
- (2010) Laura A.A. Gilliam et al. MUSCLE & NERVE
- Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
- (2010) Michael S. Ewer et al. Nature Reviews Cardiology
- Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?
- (2010) Douglas B. Sawyer et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Autophagy plays an important role in Sunitinib-mediated cell death in H9c2 cardiac muscle cells
- (2010) Yuqin Zhao et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity
- (2010) Brian B. Hasinoff TOXICOLOGY AND APPLIED PHARMACOLOGY
- Emerging role of neuregulin as a modulator of muscle metabolism
- (2009) Anna Gumà et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Direct effects of doxorubicin on skeletal muscle contribute to fatigue
- (2009) K van Norren et al. BRITISH JOURNAL OF CANCER
- Trastuzumab versus lapatinib: The cardiac side of the story
- (2009) Hamdy Azim et al. CANCER TREATMENT REVIEWS
- Nuclear Translocation of the Epidermal Growth Factor Receptor Family Membrane Tyrosine Kinase Receptors
- (2009) S.-C. Wang et al. CLINICAL CANCER RESEARCH
- Sunitinib-Induced Cardiotoxicity Is Mediated by Off-Target Inhibition of AMP-Activated Protein Kinase
- (2009) Risto Kerkela et al. CTS-Clinical and Translational Science
- Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle
- (2009) Laura A. A. Gilliam et al. JOURNAL OF APPLIED PHYSIOLOGY
- Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth
- (2009) Y H Zhao et al. ONCOGENE
- How mitochondria produce reactive oxygen species
- (2008) Michael P. Murphy BIOCHEMICAL JOURNAL
- Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes
- (2008) Yasuhiro Yamamoto et al. CARDIOVASCULAR RESEARCH
- AMP Activated Protein Kinase-α2 Deficiency Exacerbates Pressure-Overload–Induced Left Ventricular Hypertrophy and Dysfunction in Mice
- (2008) Ping Zhang et al. HYPERTENSION
- Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent Pathways
- (2008) Leo I. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanisms of Myocyte Cytotoxicity Induced by the Multiple Receptor Tyrosine Kinase Inhibitor Sunitinib
- (2008) B. B. Hasinoff et al. MOLECULAR PHARMACOLOGY
- Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
- (2008) Scott K. Powers et al. PHYSIOLOGICAL REVIEWS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started